Christopher J Morabito
Technik-/Wissenschafts-/F&E-Leiter bei ASTRIA THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Christopher J Morabito
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTRIA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2022 | - |
Karriereverlauf von Christopher J Morabito
Ehemalige bekannte Positionen von Christopher J Morabito
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FULCRUM THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.05.2021 | 13.07.2022 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 | 01.07.2020 |
MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.10.2010 | 01.04.2014 |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Christopher J Morabito
Franklin & Marshall College | Undergraduate Degree |
Penn State Hershey College of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Japan | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
ASTRIA THERAPEUTICS, INC. | Health Technology |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
FULCRUM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Christopher J Morabito
- Erfahrung